Terms: = Sarcomas AND APC, DP2, 324, ENSG00000134982, P25054, FPC, GS, DP3, DP2_5 AND Clinical Outcome
5 results:
1. APOBEC3C is a novel target for the immune treatment of lower-grade gliomas.
Zhao S; Li Y; Xu J; Shen L
Neurol Res; 2024 Mar; 46(3):227-242. PubMed ID: 38007705
[TBL] [Abstract] [Full Text] [Related]
2. [clinical outcome of allogeneic hematopoietic stem cell transplantation in the treatment of 9 myeloid leukemia patients with granulocytic sarcoma].
Liang LJ; Zhou J; Zhang YL; Fu YW; Zu YL; Yu FK; Lin QD; Han LJ; Wang Q; Fang BJ; Wei XD; Song YP
Zhonghua Nei Ke Za Zhi; 2018 Mar; 57(3):216-219. PubMed ID: 29518868
[TBL] [Abstract] [Full Text] [Related]
3. Integrated FDG-PET/CT for detection, therapy monitoring and follow-up of granulocytic sarcoma. Initial results.
Aschoff P; Häntschel M; Oksüz M; Werner MK; Lichy M; Vogel W; Pfannenberg C
Nuklearmedizin; 2009; 48(5):185-91. PubMed ID: 19710955
[TBL] [Abstract] [Full Text] [Related]
4. Granulocytic sarcoma: 32 cases and review of the literature.
Paydas S; Zorludemir S; Ergin M
Leuk Lymphoma; 2006 Dec; 47(12):2527-41. PubMed ID: 17169797
[TBL] [Abstract] [Full Text] [Related]
5. The prognostic relevance of histological type in uterine sarcomas: a Cooperation Task Force (CTF) multivariate analysis of 249 cases.
Gadducci A; Sartori E; Landoni F; Zola P; Maggino T; Cosio S; Tisi G; Lissoni A; Ferrero AM; Cristofani R
Eur J Gynaecol Oncol; 2002; 23(4):295-9. PubMed ID: 12214727
[TBL] [Abstract] [Full Text] [Related]
